JABER HUSAM JARADAT, M.D.
Medical Intern | Physician–Scientist | Founder of BrighterUs | AACR GSITA Awardee
Amman, Jordan • +962-7806-78893 • jaberjaradat2002@gmail.com
Professional Profile
Medical doctor and current intern (Mutah University, Class of 2026; Al-Bashir Hospital) pursuing U.S. Internal Medicine residency training, with comprehensive experience across inpatient and outpatient care and an academic focus in translational oncology. Author/co-author of 40+ peer-reviewed scholarly outputs and recipient of the 2026 AACR Global Scholar-in-Training Award. Research expertise spans multi-omics bioinformatics, machine learning, evidence synthesis, and immunohistochemistry. Founder of BrighterUs, a patient-centered digital cancer support platform. Career goal: Internal Medicine and oncology at the intersection of clinical care, precision medicine, and computational research.
Education & Examinations
Faculty of Medicine, Mutah University — Al-Karak, Jordan
Clinical Experience
- Provide supervised inpatient and outpatient care across medical and surgical services, including daily clinical assessment, evidence-based management, and documentation.
- Participate in ward rounds, emergency acute evaluations, intensive diagnostic workups, and multidisciplinary tumor boards and care conferences.
- Perform and assist with core clinical procedures including arterial blood gas sampling, IV line placement, venipuncture, urinary catheterization, wound management, and suturing.
- Completed comprehensive core clinical rotations across Internal Medicine, General Surgery, Pediatrics, Obstetrics & Gynecology, Psychiatry, Family Medicine, and Emergency Medicine.
- Actively participated in inpatient and outpatient diagnostic evaluations, bedside rounds, structured case presentations, and supervised clinical therapeutic planning.
- Completed focused clinical electives in Internal Medicine and General Surgery with direct engagement in inpatient hospital rounds, outpatient clinics, and pre-/post-operative care.
Research Experience & Collaborations
- Collaborate with translational oncology teams (e.g., Dr. Anwaar Saeed’s group at UPMC Hillman Cancer Center and Dr. Abdul Rafeh Naqash’s team at OU Stephenson Cancer Center) on high-dimensional multi-omics, biomarker discovery, and immuno-oncology projects.
- Develop machine learning and survival regression models for prognostic biomarker identification and clinical outcome risk stratification.
- Analyze bulk RNA-seq, single-cell RNA-seq (scRNA-seq), scATAC-seq, and spatial transcriptomics datasets using reproducible R and Python workflows.
- Design and validate tumor-microenvironment and inflammation-associated gene expression signatures across solid neoplasms (NSCLC, HCC, Sarcomas, Bladder).
- Contribute to wet-lab validation via immunohistochemistry (IHC), tissue processing, slide staining optimization, and digital pathology quantification with QuPath.
- Lead and author systematic reviews and Bayesian network meta-analyses evaluating novel oncologic treatments aligned with PRISMA guidelines.
Honors & Awards
- Global Scholar-in-Training Award (GSITA), American Association for Cancer Research (AACR), 2026
- Mutah University Junior Researcher Award for Excellence, Mutah University Faculty of Medicine, 2025–2026
Conference Presentations
- AACR Annual Meeting 2026, San Diego, USA — Integrated bulk and single-cell transcriptomics reveal PARL as a mitochondrial regulator associated with immunometabolic reprogramming in NSCLC (Poster)
- ASCO GI Cancers Symposium 2025, San Francisco, USA — Prognostic immune cell landscape in HCC progression (Poster)
- American Academy of Neurology (AAN) Annual Meeting 2025, San Diego, USA — CNS Lymphoma meta-analysis (Poster)
- Mutah University Faculty of Medicine Conferences (1st & 2nd), Al-Karak, Jordan (Oral & Poster)
- 5th International Medical Conference of Al-Karak, Jordan (Oral presentation)
Technical & Experimental Skills
Selected Peer-Reviewed Bibliography (40+ Scholarly Outputs)
View full bibliography →- Al-zu'bi B, Jaradat JH, et al. Glypican-1 in rhabdomyosarcoma: a multi-omics exploration of a targetable biomarker. Current Cancer Drug Targets. 2026.
- Bahr A, Jaradat JH, et al. Trispecific antibodies: from challenges to integration in cancer therapy. Critical Reviews in Oncology/Hematology. 2026.
- Jaradat JH, et al. Efficacy and safety of ibrutinib in CNS lymphoma: a meta-analysis. Critical Reviews in Oncology/Hematology. 2024.
- Jaradat JH, et al. HOOK3 amplification as a biomarker in bladder cancer. Anticancer Research. 2025.
- Al-zu'bi B, Jaradat JH, et al. Expression and clinical significance of cytochrome 1B1 in bone sarcomas. Pharmaceuticals. 2025.
- Alomari L, Jaradat JH, et al. A clustering-based machine learning approach for mortality prediction in gastrointestinal bleeding: development and validation. Gastro Hep Advances. 2026.
- Al-Sarireh YM, Jaradat JH, et al. Characterization of CYP4B1 expression in breast carcinoma through immunohistochemistry and in silico modeling. Breast Cancer: Targets and Therapy. 2026.
- Jaradat JH, et al. The multifaceted role of STRIP2 in disease pathogenesis and cancer progression. Anticancer Research. 2024.
- Jaradat JH, et al. The multifaceted role of AASDH: from metabolic regulation to cancer and cardiomyopathies. Anticancer Research. 2025.
- Eldeeb HA, Jaradat JH, et al. Comparative analysis of transradial vs. transfemoral approaches in radioembolization for liver tumors: a meta-analysis. Cardiovascular and Interventional Radiology. 2024.
- Jaradat JH, et al. Goalie phenomenon: unveiling hidden health conditions in young athletes. Health Care Science. 2025.
- Nasser A, Jaradat JH, et al. Endoscopic retrograde cholangiopancreatography for non-surgical bronchobiliary fistula resolution after hydatid cyst resection. İstanbul Tıp Fakültesi Dergisi. 2026.
- Seraj I, Jaradat JH, et al. Vaccines for Alzheimer's disease: a brief scoping review. Neurological Sciences. 2025.
- Al Shabilat SA, Jaradat JH, et al. COVID-19 severity and lab abnormalities in G6PD-deficient patients: meta-analysis. Oman Medical Journal. 2026.
- Nashwan AJ, Jaradat JH, et al. Iron overload in CKD patients on peritoneal dialysis: a scoping review. Health Science Reports. 2024.